Cirrus launches ClearEars to help prevent swimmer’s ear
COLD SPRING HARBOR, N.Y. Cirrus Healthcare Products recently introduced its latest ear care aisle innovation—ClearEars. The product is designed to absorb trapped water in the ear from swimming, bathing and showering, helping to prevent ear infections and swimmer’s ear.
The product also serves as an alcohol-free alternative to other ear-drying products on the market. To help support the launch, Cirrus will be promoting the product with $3 million in advertising and public relations efforts.
Google tracks flu trends through requests via search engine
SAN FRANCISCO Google has found a way to track the spread of the flu by taking note of users who type phrases related to the flu into its search engine and reporting them through a new service called Google Flu Trends.
This may enable local outbreaks to be detected before health officials detect them, tests of the site have shown.
According to The New York Times, searches for flu-related information on Google increased in mid-Atlantic U.S. states increased two weeks before the Centers for Disease Control and Prevention reported an increase in the incidence of flu in those states.
J&J recalls lots of Infants’ Mylicon Gas Relief Dye Free
FORT WASHINGTON, Pa. Johnson & Johnson-Merck Consumer Pharmaceuticals Company Monday evening voluntarily recalled approximately 12,000 units of Infants’ Mylicon Gas Relief Dye Free (simethicone-antigas) non-staining sold in 1-ounce plastic bottles that were distributed after Oct. 5 because some of the bottles could include metal fragments that were generated during the manufacturing process.
Although the potential for serious medical events is low, the company is implementing this recall to the consumer level as a precaution. If any medical events were to occur, most are expected to be temporary and resolve without medical treatment. Parents who have given the product to their infant and are concerned should contact their health care provider immediately.
The company is taking this action in consultation with the Food and Drug Administration, J&J reported.